BETHESDA, Md. (AP) — BETHESDA, Md. (AP) — Northwest Biotherapeutics Inc. (NWBO) on Friday reported a loss of $28.8 million in its third quarter. The Bethesda, Maryland-based company said it had a loss of 2 cents per share. The cancer drug developer posted revenue of $883,000 in the period. _____ This story was generated by...